OverviewChartNewsTraderScreen

Titan Pharmaceuticals/  US8883147055  /

IEX
2024-04-26  3:41:05 PM Chg. +0.40 Volume Bid- Ask- High Low
7.45USD +5.67% 200
Turnover: 1,489		 -Bid Size: - -Ask Size: - 7.45 7.44
GlobeNewswire 02-08 BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
GlobeNewswire 01-25 Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
GlobeNewswire 2023-12-28 Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
GlobeNewswire 2023-10-16 Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company'...
GlobeNewswire 2023-10-09 Ashvattha Therapeutics Announces Appointment of Dr. Sakura Minami as Vice President of Translational...
GlobeNewswire 2023-09-18 Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock
GlobeNewswire 2019-04-18 Detailed Research: Economic Perspectives on TransAct Technologies, Lifeway Foods, ImmuCell, Digirad,...
GlobeNewswire 2019-03-20 Global Opioid Use Disorder (OUD) Opportunity Analysis and Forecasts 2018-2027: Experienced and New P...
GlobeNewswire 2019-02-11 Titan Pharmaceuticals Selects Life Sciences Business Intelligence CRM Innovator, TikaMobile, to Empo...
GlobeNewswire 2018-08-16 Spring Bank Pharmaceuticals, Inc. Appoints Scott Smith to its Board of Directors
GlobeNewswire 2018-03-19 Soricimed Announces the Appointment of Dr. Marc Rubin and Mr. Vaughn Embro-Pantalony to Board of Dir...
GlobeNewswire 2017-10-13 Opiant Pharmaceuticals, Inc. Reports Fiscal Fourth Quarter and Full Year 2017 Financial Results and ...
GlobeNewswire 2017-10-02 Opiant Pharmaceuticals and Titan Pharmaceuticals Collaborate to Explore a New Approach to Opioid Use...